Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 3,458 | 1,143 | 0 | 0 | 0 |
| Gross Profit | 3,458 | 1,143 | N/A | N/A | N/A |
| Operating Expenses | 40,228 | 39,839 | 23,234 | 7,658 | 1,929 |
| Operating Income | -36,769 | -38,697 | -23,234 | -7,658 | -1,929 |
| Other Income | 483 | 541 | 0 | 0 | 0 |
| Pre-tax Income | -36,287 | -38,155 | -23,234 | -7,658 | -1,929 |
| Income Tax | 413 | 825 | N/A | N/A | N/A |
| Net Income Continuous | -36,699 | -38,980 | -23,234 | -7,658 | -1,929 |
| Net Income | $-36,699 | $-38,980 | $-23,234 | $-7,658 | $-1,929 |
| EPS Basic Total Ops | -1.66 | -1.94 | -2.16 | -1.03 | -0.34 |
| EPS Basic Continuous Ops | -1.67 | -1.94 | -2.16 | -1.03 | -0.34 |
| EPS Diluted Total Ops | -1.66 | -1.94 | -2.16 | -1.03 | -0.34 |
| EPS Diluted Continuous Ops | -1.67 | -1.94 | -2.16 | -1.03 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -1.66 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-36,031 | $-37,937 | $-22,814 | $-7,456 | $-1,884 |